A9585 HCPCS code: Injection, gadobutrol, 0.1 ml
A9585 is the HCPCS Level II code for injection, gadobutrol, 0.1 ml. In 2024 Medicare paid an average of $0.24 per service for A9585 across 21,562,873 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 8% from 2022 to 2024 (19,912,519 to 21,562,873 services). In 2024, about 6,329 clinicians billed Medicare for A9585 for 226,479 beneficiaries; California, New York, Florida accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2012-01-01 |
| Last action effective | 2012-01-01 |
Who bills A9585 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 6,329 |
| Medicare beneficiaries | 226,479 |
| States with claims | 50 |
| Share of services in top 3 states (California, New York, Florida) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9585, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 19,912,519 | 215,693 | $0.33 | $0.26 |
| 2023 | 20,574,150 | 220,227 | $0.33 | $0.26 |
| 2024 | 21,562,873 | 226,479 | $0.31 | $0.24 |
States with the most A9585 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 3,932,143 | $0.25 |
| New York | 3,016,292 | $0.25 |
| Florida | 2,070,304 | $0.25 |
| Minnesota | 1,780,333 | $0.24 |
| Virginia | 1,105,989 | $0.24 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Clinical: Data |
| practitioner claims | 300 | Clinical: Data |
Medicare policy articles for this code
- A57206: Billing and Coding: Lumbar MRI (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
Covered diagnoses (3,360 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| A02.21 | Salmonella meningitis | 1 |
| A02.24 | Salmonella osteomyelitis | 1 |
| A17.0 | Tuberculous meningitis | 1 |
| A17.1 | Meningeal tuberculoma | 1 |
| A17.81 | Tuberculoma of brain and spinal cord | 1 |
| A17.82 | Tuberculous meningoencephalitis | 1 |
| A17.83 | Tuberculous neuritis | 1 |
| A18.01 | Tuberculosis of spine | 1 |
| A27.81 | Aseptic meningitis in leptospirosis | 1 |
| A39.0 | Meningococcal meningitis | 1 |
Showing 10 of 3,360. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for A9585
- 2012-01-01: A9585 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9585?
A9585 is the HCPCS Level II code for injection, gadobutrol, 0.1 ml. Short descriptor: "Gadobutrol injection".
How much does Medicare pay for A9585?
In 2024, the average Medicare payment was $0.24 per service (average allowed $0.31).
Does Medicare cover A9585?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for A9585?
Medicare policy articles that cite A9585 list 3,360 covered ICD-10-CM diagnosis codes across 1 article. The most cited include A02.21 (Salmonella meningitis), A02.24 (Salmonella osteomyelitis), A17.0 (Tuberculous meningitis). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of A9585 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9585
- Watch A9585 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9585
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.